In this investigation, we observed diminished levels of SLC7A11, FTH1, GPX4, and GSH, along with elevated ROS generation in LPS-treated FHC cells and NEC rat intestinal tissues, however, the miR-155 inhibitor significantly reversed these effects. This evidence concerns the gene GPX4 and necrotizing enterocolitis.